🏢 官网IRLABCodex · 实盘不做把握 2/10
北京时间·🕒 发布 19:00:00时区推断·⟳ 抓取 19:06:03·⚡ 决策 07-22 19:07:17 +1m14s·97.1 天前
Standard BioTools宣布将于8月5日盘后披露二季度业绩
本次只是公司预告二季度财报披露时间，没有披露收入、利润、订单、指引或其他可改变预期的经营信息。
📄 原文LAB↗ 原文
Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026
Jul 22, 2026 PDF Version BOSTON, Mass. , July 22, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today a…
不做 Standard BioTools（LAB.US）
仅为二季度财报披露日期预告，不含业绩超预期、指引调整或公司级新增信息，无法形成正期望交易。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-22 · 扩散 low · price-in 风险 medium ↗
关键理由
- 本次只是公司预告二季度财报披露时间，没有披露收入、利润、订单、指引或其他可改变预期的经营信息。
主要风险
- 若8月5日正式财报披露超预期，需由新信号重新研判。
原文全文
展开原文 · 1,284 字
Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026
Jul 22, 2026
PDF Version
BOSTON, Mass.
,
July 22, 2026
(GLOBE NEWSWIRE) --
Standard BioTools Inc.
(NASDAQ: LAB) today announced that it will publish its second quarter 2026 financial results on
Wednesday, August 5, 2026
, after U.S. market close.
About
Standard BioTools, Inc.
(NASDAQ: LAB), is committed to setting the new standard in the life science tools industry through strategic consolidation, best-in-class operations and a world-class management team. The Company's established portfolio includes essential, standardized next-generation solutions designed to help biomedical researchers develop better therapeutics faster.
For Research Use Only. Not for use in diagnostic procedures.
Limited Use Label License and other terms may apply:
standardbio.com/legal/terms-and-conditions/
.
Patent and License Information:
standardbio.com/legal/notices
Trademarks:
standardbio.com/legal/trademarks
. Any other trademarks are the sole property of their respective owners. ©2026
(f.k.a.
Fluidigm Corporation
). All rights reserved.
Standard BioTools
products are provided for Research Use Only. Not for use in diagnostic procedures.
Investor Contact:
[email protected]
Source: Standard BioTools Inc.
Jul 22, 2026
PDF Version
BOSTON, Mass.
,
July 22, 2026
(GLOBE NEWSWIRE) --
Standard BioTools Inc.
(NASDAQ: LAB) today announced that it will publish its second quarter 2026 financial results on
Wednesday, August 5, 2026
, after U.S. market close.
About
Standard BioTools, Inc.
(NASDAQ: LAB), is committed to setting the new standard in the life science tools industry through strategic consolidation, best-in-class operations and a world-class management team. The Company's established portfolio includes essential, standardized next-generation solutions designed to help biomedical researchers develop better therapeutics faster.
For Research Use Only. Not for use in diagnostic procedures.
Limited Use Label License and other terms may apply:
standardbio.com/legal/terms-and-conditions/
.
Patent and License Information:
standardbio.com/legal/notices
Trademarks:
standardbio.com/legal/trademarks
. Any other trademarks are the sole property of their respective owners. ©2026
(f.k.a.
Fluidigm Corporation
). All rights reserved.
Standard BioTools
products are provided for Research Use Only. Not for use in diagnostic procedures.
Investor Contact:
[email protected]
Source: Standard BioTools Inc.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。